<DOC>
	<DOCNO>NCT00679146</DOCNO>
	<brief_summary>Primary Objective : To demonstrate superiority oral fix - combination muscle relaxant , thiocolchicoside ( TCC ) non steroidal anti-inflammatory drug , ketoprofen , oral TCC , average pain within last 24 hour adult suffer acute non specific low back pain episode recent onset Secondary Objective : To compare safety oral combination oral TCC alone</brief_summary>
	<brief_title>Efficacy Safety Combination Thiocolchicoside+Ketoprofen Compared Thiocolchicoside Twice Day 7 Days Patients Suffering From Acute Non Specific Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>List Inclusion Exclusion criterion : Non specific low back pain acute episode recent onset ( &lt; 48 hour ) define average pain within last 24 hour equal 50 mm Visual Analogue Scale ( VAS ) Low back pain diagnosis category 1 ( low back pain radiate farther intergluteal fold ) 2 ( low back pain radiate farther knee ) , define International Paris Task Force Back Pain Exclusion criterion relate study methodology : Low back pain due vertebral collapse mechanical origin ( suspected history take physical examination ) , neoplasm , infection inflammatory disorder , Low back pain diagnosis category 3 ( low back pain radiate beyond knee , neurologic sign ) 4 ( low back pain radiating precise entire leg dermatome , without neurologic sign ) , define International Paris Task Force Back Pain History inflammatory arthritis large joint , History seizure disorder , History malignant tumour , Treatment steroidal agent ( include aspirin ) two day prior prospective inclusion , prolong used corticosteroid , Treatment NSAIDs muscle relaxant opioid analgesic within 3 day admission , Psychiatric mental disease , Immunosuppression , HIV , Inclusion another study past six month previous inclusion study , History alcohol , drug narcotic abuse Recent history violent trauma , Constant progressive , non mechanical pain ( relief bed rest ) , Thoracic pain , Patient systemically unwell , Unexplained weight loss , Widespread neurological symptom ( include cauda equine syndrome ) , Structural deformity Fever , Clinical significant renal dysfunction define Creatinine &gt; 1.5 UNL , Clinically significant hepatic dysfunction define : Total Bilirubin &gt; 2 UNL SGOT ( AST ) &gt; 1.5 UNL SGPT ( ALAT ) &gt; 1.5 UNL Alkaline Phosphatase &gt; 1.5 UNL Patients receive therapy ( physiotherapy , physical manipulation , invasive intervention , acupuncture therapy ... ) within last 48 hour . Exclusion criterion related trial drug : Pregnancy , breast feeding woman childbearing potential use efficient contraception . Patient Intra Uterine Device use another form contraception efficacy IUD may reduce ketoprofen . Exclusion criterion related thiocolchicoside : Known suspected hypersensitivity thiocolchicoside Exclusion criterion related ketoprofen : Uncontrolled heart failure , Arterial Hypertension ( SBP &gt; 140 mmHg DBP &gt; 90 mmHg ) , Stroke myocardial infarction past , Myopathy Myasthenia , History active peptic ulcer gastrointestinal ( GI ) bleeding , history gastric pain NSAIDs , History NSAID/aspirininduced asthma , Known suspect hypersensitivity ketoprofen . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>